[Nang Kuang] Announcement regarding the approval of lifting non-compete restrictions for directors at the 2026 Annual General Meeting
Nang Kuang Pharmaceutical announced that the 2026 AGM approved the lifting of non-compete restrictions for six directors with 99.63% approval, allowing them to engage in related business activities.
📋 Article Processing Timeline
- 📰 Published: May 28, 2026 at 09:00
- 🔍 Collected: May 29, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 31, 2026 at 18:34 (58h 34m after Collected)
1. Date of resolution: 2026/05/28. 2. Names and titles of directors permitted to engage in competitive activities: (1) Chang Po-jen, (2) Hsu Li-chun, (3) Hsu Ya-fen, (4) Wu Ya-chuan, (5) Lin Chih-lung, (6) Wang Yu-pei. 3. Items permitted: Directors may engage in business within the company's scope for themselves or others, provided it does not harm the company's interests. 4. Duration: During their tenure. 5. Voting results: 61,844,740 votes in favor, 105,508 against. Passed with 99.63% approval. 6. Mainland China business: Not applicable.
FAQ
What is a non-compete waiver?
It allows directors to engage in business activities that might otherwise conflict with the company.